1 – 38 of 38
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Functional In Vivo Screening Identifies microRNAs Regulating Metastatic Dissemination of Prostate Cancer Cells to Bone Marrow
(
- Contribution to journal › Article
-
Mark
CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer.
(
- Contribution to journal › Article
- 2022
-
Mark
Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors
(
- Contribution to journal › Article
- 2021
-
Mark
Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Abstract CT074: Pre-existing ESR1 mutations in early-stage primary breast cancer predict failure of endocrine therapy and poor survival
(
- Contribution to journal › Published meeting abstract
- 2016
-
Mark
Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
(
- Contribution to journal › Article
-
Mark
Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing.
(
- Contribution to journal › Article
-
Mark
Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients.
(
- Contribution to journal › Article
-
Mark
Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours.
(
- Contribution to journal › Article
-
Mark
Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy.
(
- Contribution to journal › Article
-
Mark
Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing.
(
- Contribution to journal › Article
-
Mark
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.
(
- Contribution to journal › Article
-
Mark
Whole genome sequencing of primary breast cancers and matched distant metastases
2015) American Association for Cancer Research (AACR) 106th Annual Meeting 2015 In Cancer Research 75(15).(
- Contribution to journal › Published meeting abstract
- 2014
-
Mark
Molecular and genetic diversity in the metastatic process of melanoma.
(
- Contribution to journal › Article
- 2012
-
Mark
Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition.
(
- Contribution to journal › Article
-
Mark
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.
(
- Contribution to journal › Article
-
Mark
The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.
(
- Contribution to journal › Article
- 2011
-
Mark
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
(
- Contribution to journal › Article
- 2009
-
Mark
3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma
(
- Contribution to journal › Article
- 2008
-
Mark
Exploring the two-gene ratio in breast cancer-independent roles for HOXB13 and IL17BR in prediction of clinical outcome
(
- Contribution to journal › Article
-
Mark
Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer
(
- Contribution to journal › Article
-
Mark
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair
(
- Contribution to journal › Article
-
Mark
The CD44(+)/CD24(-) phenotype is enriched in basal-like breast tumors
(
- Contribution to journal › Article
- 2007
-
Mark
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
(
- Contribution to journal › Article
-
Mark
Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers
(
- Contribution to journal › Article
-
Mark
Estrogen receptor beta expression is associated with tamoxifen response in ER alpha-negative breast carcinoma
(
- Contribution to journal › Article
- 2006
-
Mark
Microarrays in breast cancer research and clinical practice - the future lies ahead
(
- Contribution to journal › Scientific review
-
Mark
Is the small heat shock protein alphaB-crystallin an oncogene?
(
- Contribution to journal › Article
- 2005
-
Mark
Estrogen receptor alpha and beta in breast cancer - gene expression profiles and clinical implications
2005)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Estrogen receptor (ER)-beta has favorable independent prognostic value for ER-alfa negative breast cancer patients receiving adjuvant tamoxifen
(
- Contribution to journal › Published meeting abstract
- 2004
-
Mark
Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles.
(
- Contribution to journal › Article
- 2003
-
Mark
Expression profiling to predict outcome in breast cancer: the influence of sample selection
(
- Contribution to journal › Article
- 2002
-
Mark
Bioarray software environment: a platform for comprehensive management and analysis of microarray data
(
- Contribution to journal › Article
- 2001
-
Mark
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns
(
- Contribution to journal › Article
-
Mark
Gene-expression profiles in hereditary breast cancer
(
- Contribution to journal › Article
- 1999
-
Mark
Vascular endothelial growth factor (VEGF) and urokinase plasminogen activator (uPA) are independent prognostic factors for distant recurrence in premenopausal node-negative breast cancer
(
- Contribution to journal › Published meeting abstract